Pincus Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.81M Sell
2,431
-90
-4% -$106K 1.67% 13
2026
Q2
$3.02M Sell
2,521
-10
-0.4% -$10.2K 1.8% 11
2026
Q1
$2.33M Sell
2,531
-24
-0.9% -$24.3K 1.62% 13
2025
Q4
$2.75M Hold
2,555
– – 1.83% 13

Other funds holding LLY

Pincus Capital Management's LLY Position: Q3 2026 in Review

Pincus Capital Management reduced its Eli Lilly (LLY) stake by 3.6% in Q3 2026, selling an estimated $106K and leaving 2,431 shares worth $2.81M. The position accounts for 1.67% of the portfolio, ranked #13.

Pincus Capital Management first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.02M in Q2 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Pincus Capital Management held 2,431 shares of Eli Lilly worth $2.81M as of Q3 2026.
  • Pincus Capital Management sold 90 Eli Lilly shares in Q3 2026, an estimated $106K.
  • Eli Lilly made up 1.67% of Pincus Capital Management's portfolio in Q3 2026, its #13 holding.
  • Pincus Capital Management first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Pincus Capital Management's Eli Lilly position peaked at $3.02M in Q2 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Pincus Capital Management's 13F filing for Q3 2026, filed 9 Nov 2026.